Fang Y, Yang W, Cheng L, Meng F, Zhang J, Zhong Z: EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo. Acta Biomater, 2017;64:323-333. [DOI: 10.1016/j.actbio.2017.10.013].

Tai P, Chen X, Jia G, Chen G, Gong L, Cheng Y, Li Z, Wang H, Chen A, Zhang G, Zhu Y, Xiao M, Wang Z, Liu Y, Shan D, He D, Li M, Zhan T, Khan A, Li X, Zeng X, Li C, Ouyang D, Ai K, Chen X, Liu D, Liu Z, Wei D, Cao K: WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis. J Transl Med, 2023;21(1):823, [DOI: 10.1186/s12967-023-04715-1].

Pai VB, Nahata MC: Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf, 2000;22(4):263-302. [DOI: 10.2165/00002018-200022040-00002].

Wang Y, Chao X, Ahmad FUD, Shi H, Mehboob H, Hassan W: Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity. Cardiol Res Pract, 2019;2019:7395239. [DOI: 10.1155/2019/7395239].

Abdel-Daim MM, Kilany OE, Khalifa HA, Ahmed AAM: Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Cancer Chemother Pharmacol, 2017;80(4):745-753. [DOI: 10.1007/s00280-017-3413-7].

Wang ZY, Liu YY, Liu GH, Lu HB, Mao CY: l-Carnitine and heart disease. Life Sci, 2018;194:88-97. [DOI: 10.1016/j.lfs.2017.12.015].

Aboubakr M, Elsayd F, Soliman A, Fadl SE, El-Shafey A, Abdelhiee EY: L-Carnitine and vitamin E ameliorate cardiotoxicity induced by tilmicosin in rats. Environ Sci Pollut Res Int, 2020;27(18):23026-23034. [DOI: 10.1007/s11356-020-08919-6].

Mansour HH, El Kiki SM, Ibrahim AB, Omran MM: Effect of l-carnitine on cardiotoxicity and apoptosis induced by imatinib through PDGF/ PPARγ /MAPK pathways. Arch Biochem Biophys, 2021;704:108866. [DOI: 10.1016/j.abb.2021.108866].

Aboubakr M, Farag A, Elfadadny A, Alkafafy M, Soliman A, Elbadawy M: Antioxidant and anti-apoptotic potency of allicin and lycopene against methotrexate-induced cardiac injury in rats. Environ Sci Pollut Res Int, 2023;30(38):88724-88733. [DOI: 10.1007/s11356-023-28686-4].

Elkomy A, Abdelhiee EY, Fadl SE, Emam MA, Gad FA, Sallam A, Alarifi S, Abdel-Daim MM, Aboubakr M: L-Carnitine Mitigates Oxidative Stress and Disorganization of Cytoskeleton Intermediate Filaments in Cisplatin-Induced Hepato-Renal Toxicity in Rats. Front Pharmacol, 2020;11:574441. [DOI: 10.3389/fphar.2020.574441].

AlAsmari AF, Ali N, Alharbi M, Alqahtani F, Alasmari F, Almoqbel D, AlSwayyed M, Alshammari A, Alanazi MM, Alhoshani A, Al-Harbi NO: Geraniol Ameliorates Doxorubicin-Mediated Kidney Injury through Alteration of Antioxidant Status, Inflammation, and Apoptosis: Potential Roles of NF-κB and Nrf2/Ho-1. Nutrients, 2022;14(8). [DOI: 10.3390/nu14081620].

Buhl SN, Jackson KY: Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 degrees C. Clin Chem, 1978;24(5):828-831.

Neumeier D, Prellwitz W, Würzburg U, Brundobler M, Olbermann M, Just HJ, Knedel M, Lang H: Determination of creatine kinase isoenzyme MB activity in serum using immunological inhibition of creatine kinase M subunit activity. Activity kinetics and diagnostic significance in myocardial infarction. Clin Chim Acta, 1976;73(3):445-451. [DOI: 10.1016/0009-8981(76)90146-7].

Szasz G, Waldenström J, Gruber W: Creatine kinase in serum: 6. Inhibition by endogenous polyvalent cations, and effect of chelators on the activity and stability of some assay components. Clin Chem, 1979;25(3):446-452.

Aebi H: Catalase in vitro. Methods Enzymol, 1984;105:121-126. [DOI: 10.1016/s0076-6879(84)05016-3].

Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem, 1974;249(22):7130-7139.

Mihara M, Uchiyama M: Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem, 1978;86(1):271-278. [DOI: 10.1016/0003-2697(78)90342-1].

Nishikimi M, Appaji N, Yagi K: The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun, 1972;46(2):849-854. [DOI: 10.1016/s0006-291x(72)80218-3].

Bancroft J, Gamble MJNY, London, Livingstone MC: Theories and practice of histological techniques. 2013;7(12):2768-2773.

Shivakumar P, Rani MU, Reddy AG, Anjaneyulu Y: A study on the toxic effects of Doxorubicin on the histology of certain organs. Toxicol Int, 2012;19(3):241-244. [DOI: 10.4103/0971-6580.103656].

Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S: Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett, 2019;307:41-48. [DOI: 10.1016/j.toxlet.2019.02.013].

Parker MA, King V, Howard KP: Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers. Biochim Biophys Acta, 2001;1514(2):206-216. [DOI: 10.1016/s0005-2736(01)00371-6].

Khedr NF, El-Feky OA, Werida RH: L-Carnitine Mitigates Trazadone Induced Rat Cardiotoxicity Mediated via Modulation of Autophagy and Oxidative Stress. Cardiovasc Toxicol, 2022;22(9):831-841. [DOI: 10.1007/s12012-022-09759-1].

Fukai T, Folz RJ, Landmesser U, Harrison DG: Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res, 2002;55(2):239-249. [DOI: 10.1016/s0008-6363(02)00328-0].

Fattman CL, Schaefer LM, Oury TD: Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med, 2003;35(3):236-256. [DOI: 10.1016/s0891-5849(03)00275-2].

Fang YZ, Yang S, Wu G: Free radicals, antioxidants, and nutrition. Nutrition, 2002;18(10):872-879. [DOI: 10.1016/s0899-9007(02)00916-4].

Xiong C, Wu YZ, Zhang Y, Wu ZX, Chen XY, Jiang P, Guo HC, Xie KR, Wang KX, Su SW: Protective effect of berberine on acute cardiomyopathy associated with doxorubicin treatment. Oncol Lett, 2018;15(4):5721-5729. [DOI: 10.3892/ol.2018.8020].

Wei J, Yang Q, Lin L, Zhu C, Wei J: [Metformin mitigates doxorubicin-induced cardiotoxicity via the AMPK pathway]. Nan Fang Yi Ke Da Xue Xue Bao, 2023;43(10):1682-1688. [DOI: 10.12122/j.issn.1673-4254.2023.10.05].

Mustafa HN, Hegazy GA, Awdan SAE, AbdelBaset M: Protective role of CoQ10 or L-carnitine on the integrity of the myocardium in doxorubicin induced toxicity. Tissue Cell, 2017;49(3):410-426. [DOI: 10.1016/j.tice.2017.03.007].

Yalçin E, Oruç E, Cavuşoğlu K, Yapar K: Protective role of grape seed extract against doxorubicin-induced cardiotoxicity and genotoxicity in albino mice. J Med Food, 2010;13(4):917-925. [DOI: 10.1089/jmf.2009.0162].

Wang S, Kotamraju S, Konorev E, Kalivendi S, Joseph J, Kalyanaraman B: Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. Biochem J, 2002;367(Pt 3):729-740. [DOI: 10.1042/bj20020752].

Malone JI, Cuthbertson DD, Malone MA, Schocken DD: Cardio-protective effects of carnitine in streptozotocin-induced diabetic rats. Cardiovasc Diabetol, 2006;5:2. [DOI: 10.1186/1475-2840-5-2].